GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (NAS:PRQR) » Definitions » Deferred Policy Acquisition Costs

ProQR Therapeutics NV (ProQR Therapeutics NV) Deferred Policy Acquisition Costs


View and export this data going back to 2014. Start your Free Trial

What is ProQR Therapeutics NV Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


ProQR Therapeutics NV (ProQR Therapeutics NV) Business Description

Industry
Traded in Other Exchanges
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.